A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds

NCT06226714 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

840

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Meningitis

Interventions

BIOLOGICAL: MCV4
BIOLOGICAL: MPSV4

Sponsor

CanSino Biologics Inc.